TNF-α disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium

Exp Eye Res. 2013 May:110:59-69. doi: 10.1016/j.exer.2013.02.012. Epub 2013 Feb 27.

Abstract

Retinal pigment epithelial (RPE) cells form a blood-ocular barrier, and their polarized property is crucial for maintaining the barrier functions. Tumor necrosis factor alpha (TNF-α), a major pleotropic inflammatory cytokine that disrupts the barrier function and eventual angiogenesis, is expressed in the choroidal neovascularizations of age-related macular degeneration eyes. Thus, it most likely plays an important role in the progression of the disease. The purpose of this study was to compare the effects of TNF-α on the barrier function of polarized RPE cells. Non-polarized RPE cells were used as negative controls. Isolated porcine RPE cells were seeded on Transwell™ membranes. The polarization of the RPE cells was determined by their high transepithelial electrical resistance (TER >150 Ω cm(2)) and by their differential secretion of vascular endothelial growth factor (lower layer/upper layer >2.5X). Polarized RPE cells were incubated with 10 ng/ml of TNF-α and the TER was measured. TNF-α significantly decreased the TER of polarized RPE cells by 17.6 ± 2.7% (P < 0.001) of the control at 24 h and that of non-polarized RPE cells by 5.4 ± 6.5% (P = 0.401). The p38 mitogen-activated protein kinase (MAPK) inhibitor, SB203580, blocked the effects of TNF-α of decreasing the TER. Cell junction-related molecules, e.g., ZO-1, located between cells in control RPE cells, were disassembled by TNF-α, and this breakdown was suppressed by SB203580 in polarized RPEs. These results indicate that the breakdown of the RPE barrier function was caused exclusively by TNF-α in polarized RPEs, and TNF-α was acting through the p38 MAPK pathways. Investigations of polarized RPE cells should be more suitable for in vitro studies of the pathophysiology of retinochoroidal diseases.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology
  • Animals
  • Anthracenes / pharmacology
  • Blood-Retinal Barrier / drug effects*
  • Blotting, Western
  • Cell Polarity
  • Cells, Cultured
  • Electric Impedance
  • Enzyme Inhibitors / pharmacology
  • Enzyme-Linked Immunosorbent Assay
  • Imidazoles / pharmacology
  • In Situ Nick-End Labeling
  • Microscopy, Electron, Scanning
  • Pyridines / pharmacology
  • Recombinant Proteins / pharmacology
  • Retinal Pigment Epithelium / drug effects*
  • Retinal Pigment Epithelium / metabolism
  • Swine
  • Tight Junction Proteins / metabolism
  • Tight Junctions / drug effects*
  • Tight Junctions / metabolism
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Vascular Endothelial Growth Factor A / metabolism
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Amino Acid Chloromethyl Ketones
  • Anthracenes
  • Enzyme Inhibitors
  • Imidazoles
  • Pyridines
  • Recombinant Proteins
  • Tight Junction Proteins
  • Tumor Necrosis Factor-alpha
  • Vascular Endothelial Growth Factor A
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • pyrazolanthrone
  • p38 Mitogen-Activated Protein Kinases
  • SB 203580